Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Recent Price Declines
Shukra Pharmaceuticals Ltd is experiencing notable selling pressure, with a three-day decline totaling 5.86%. Despite a strong monthly performance, the stock has underperformed recently, raising concerns about its short-term trajectory. It remains above several moving averages but is below its 5-day average, influencing current market activity.
Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with today's trading session showing only sellers in the market. The stock has experienced a consecutive decline over the past three days, resulting in a total loss of 5.86%. Today, Shukra Pharmaceuticals reported a performance drop of 1.99%, notably underperforming the Sensex, which gained 0.61%.In the context of recent performance, Shukra Pharmaceuticals has seen a weekly decline of 3.99%, while the Sensex rose by 2.81%. Despite a strong monthly performance of 19.49% compared to the Sensex's modest 0.22%, the stock's short-term trajectory raises concerns. Over the last three months, Shukra Pharmaceuticals has surged by 131.87%, contrasting sharply with the Sensex's decline of 2.74%.
The stock opened at 236 and has remained at this price throughout the trading day. While it is trading above its 20, 50, 100, and 200-day moving averages, it is currently below its 5-day moving average. This combination of factors may be contributing to the heightened selling activity observed today.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
